+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Parenteral Nutrition: Global Strategic Business Report

  • PDF Icon

    Report

  • 272 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1882097

Global Parenteral Nutrition Market to Reach $11.8 Billion by 2030

The global market for Parenteral Nutrition estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$11.8 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$4.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Parenteral Lipid Emulsion segment is readjusted to a revised 8.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 12.9% CAGR

The Parenteral Nutrition market in the U.S. is estimated at US$1.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Select Competitors (Total 36 Featured) -

  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • Grifols International S.A.
  • ICU Medical Inc.
  • Otsuka Pharmaceutical Factory Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Sino-Swed Pharmaceutical Corp. Ltd.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Parenteral Nutrition

What is the estimated value of the Global Market for Parenteral Nutrition?

The Global Market for Parenteral Nutrition was estimated to be valued at $6 Billion in 2020.

What is the growth rate of the Global Market for Parenteral Nutrition?

The growth rate of the Global Market for Parenteral Nutrition is 6.6%, with an estimated value of $9.4 Billion by 2027.

What is the forecasted size of the Global Market for Parenteral Nutrition?

The Global Market for Parenteral Nutrition is estimated to be worth $9.4 Billion by 2027.

Who are the key companies in the Global Market for Parenteral Nutrition?

Key companies in the Global Market for Parenteral Nutrition include Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., Fresenius KABI AG, Grifols International S.A., ICU Medical Inc., Otsuka Pharmaceutical Factory Inc., Sichuan Kelun Pharmaceutical Co. Ltd. and Sino.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
  • Recent Market Activity
  • Malnutrition Related to Chronic Medical Conditions Fuels Demand for PN Products
  • The Road Ahead
  • Developed Economies Lead, Developing Regions to Propel Future Growth
  • Single Dose Amino Acid Solutions - Major Share of PN Solutions Market
  • Competitive Landscape
  • Parenteral Nutrition - Global Key Competitors Percentage Market Share in 2022 (E)
  • Parenteral Nutrition Competitor Market Share Scenario Worldwide (in %): 2020 & 2025
  • Parenteral Nutrition Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
  • Allergan plc (Ireland)
  • Amanta Healthcare Ltd (India)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (USA)
  • Fresenius KABI AG (Germany)
  • Grifols International S.A. (Spain)
  • ICU Medical, Inc. (USA)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)
  • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Sino-Swed Pharmaceutical Corp. Ltd. (China)
3. MARKET TRENDS & DRIVERS
  • Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
  • Increase in Healthcare Spending Bodes Well for Parenteral Nutrition Market
  • Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
  • Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
  • Cancer Patients - the Highest PN Users
  • Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
  • Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Parenteral Nutrition Market
  • Persistent Threat of HIV/AIDS - A Peek at Global HIV Statistics
  • Diabetes Mellitus: PN Therapy Indicated for Patients with Non-functional GI Tract
  • Global Diabetic Statistics - Opportunity Indicators
  • Rising Number of Premature Births Enhances Need for Parenteral Nutrition
  • Preterm Birth Statistics from WHO
  • Inadequate Physiological Development Raises Need for Tube Feeding in Infants
  • Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
  • Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market
  • Growing Demand for Home Intravenous Nutritional Therapies
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Popularity of Intravenous Vitamin C for Cancer Treatment
  • Increasing Demand for Peripheral Intravenous Nutrition
  • Iron Replacement Therapies - A Potential Market Segment
  • Popularity of TPN as Beauty Treatment Raises Ethical and Safety Concerns
  • Pharmaceutical Industry Participants Migrate from Concentrated Vials to Premixed Solutions
  • Vial Dilution and Potential Risks
  • Premixed Bags Present Efficient Delivery System
  • Switching from Vials to Premixed Bags
  • Challenges Confronting Production of Parenteral Products
  • Continuous Supply of Raw Material: Crucial for Production
  • Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Limiting Medication Errors - A Key Concern
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Parenteral Nutrition Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Single Dose Amino Acid Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Single Dose Amino Acid Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Single Dose Amino Acid Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Trace Elements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Trace Elements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Trace Elements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 19: World 16-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 22: World 16-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Children & Newborns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 24: World Historic Review for Children & Newborns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: World 16-Year Perspective for Children & Newborns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 30: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Parenteral Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • Grifols International S.A.
  • ICU Medical Inc.
  • Otsuka Pharmaceutical Factory Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Sino-Swed Pharmaceutical Corp. Ltd.